(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) SYMBICORT is a combination asthma medication that contains both an inhaled corticosteroid (ICS ...
DENVER--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced results from a long-term study comparing SYMBICORT ® (budesonide/ formoterol fumarate dihydrate) Inhalation Aerosol 160/4.5 mcg with ...
WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced the publication of data demonstrating that SYMBICORT Inhalation Aerosol 320/9 µg twice daily had a safety profile similar to ...
WILMINGTON, Del.--(BUSINESS WIRE)--Results from a US comparative effectiveness study of two maintenance treatment options for patients with a history of chronic obstructive pulmonary disease (COPD) ...
AstraZeneca (NYSE:AZN) announces successful results from two clinical trials assessing the expanded use of SYMBICORT (budesonide/formoterol fumarate dihydrate ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Symbicort Turbuhaler contains two active ingredients in one inhaler: ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Symbicort Rapihaler contains two active ingredients in one inhaler: ...
The FDA has approved AstraZeneca's Symbicort for a new use. Symbicort can now be used to treat asthma and chronic bronchitis, making it far more competitive with the blockbuster Advair. Report Let ...
The SmartTouch for Symbicort is a monitoring device that is installed onto the patient's inhaler to track and improve medication adherence. The Food and Drug Administration (FDA) has granted Adherium ...
AstraZeneca today announced that the European Patent Office (EPO) Technical Board of Appeal has made a final ruling that the European Combination patent covering the use of Symbicort (formoterol and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results